VSTA-It is also estimated that about one-third of all potential new drugs candidates fail in preclinical or clinical trials due to safety concerns. VSTA picks these up after other companies invest millions of dollars and years of research.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.